The use of therapeutic drug monitoring for early identification of vedolizumab response in saudi arabian patients with inflammatory bowel disease

HIGHLIGHTS

• who: Doaa Anbarserry from the DepartmentAbdulaziz University have published the research: The use of therapeutic drug monitoring for early identification of vedolizumab response in Saudi Arabian patients with inflammatory bowel disease, in the Journal: Scientific Reports Scientific Reports
• what: The authors aimed to identify whether early vedolizumab trough levels could predict patient response at week 14.
• how: The results showed that clinical remission at week 14 can be predicted by early analysis of vedolizumab trough levels at week 6.

SUMMARY

Throughout the induction period, blood samples for vedolizumab trough . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.